Centerpoint Advisors, LLC Cocrystal Pharma, Inc. Transaction History

Centerpoint Advisors, LLC

  • $288 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019
SELL
$1.6 - $3.68 $800 - $1,840
-500 Closed
0 $0
Q1 2018

May 09, 2018
BUY
$3.9 - $6.9 $1,950 - $3,450
500 New
500 $3,000

About Cocrystal Pharma, Inc.

COCP Quotes by TradingView
  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $17.5M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email